Taisho Pharmaceutical Holdings Co., Ltd.’s $1.6 Billion Acquisition of Bristol-Myers Squibb’s UPSA consumer health business

Deutsche Bank Securities, Inc. and Jefferies LLC acted as exclusive financial advisors to Bristol-Myers Squibb. Kirkland & Ellis LLP, Freshfields Bruckhaus Deringer LLP and Baker &…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now